Claraphi Advisory Network, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Claraphi Advisory Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$548.35 - $738.84 $467,194 - $629,491	-852 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $153,540 - $180,194	-258 Reduced 23.24%	852 $595,000
Q4 2021 Feb 07, 2022	SELL	$543.48 - $670.97 $66,304 - $81,858	-122 Reduced 9.9%	1,110 $701,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $671,041 - $796,042	-1,169 Reduced 48.69%	1,232 $745,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $14,656 - $17,314	31 Added 1.31%	2,401 $1.34 Million
Q1 2021 Apr 30, 2021	BUY	$446.73 - $548.2 $1.06 Million - $1.3 Million	2,370 New	2,370 $1.12 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $455,827 - $594,982	-924 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $310,630 - $456,853	924 New	924 $451,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.